Navigation Links
7th International Chronic Total Occlusion Summit in New York City
Date:11/16/2009

WHAT: The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions. This year's summit will include:

  • Presentations from experts in the field
  • Case review sessions
  • Thematically organized live coronary CTO cases broadcast in high definition from Scripps Clinic and Research Foundation (La Jolla, CA) and Columbia University Medical Center (New York, NY)
  • Essential techniques, tips, and information for determining how to treat CTOs

WHY: Chronic total occlusions of coronary arteries represent one of the greatest challenges to interventional cardiologists. Successful revascularization of CTOs has been strongly associated with improved left ventricular function, freedom from angina, a reduced risk of revascularization and in several studies increased survival. Through new guidewires, novel devices, appropriate patient selection, and improved operator technique, the success rate for recanalization of complex CTOs is increasing. The novel retrograde approach to CTOs has been introduced as an alternative route for recanalization of otherwise difficult or impossible lesions.

WHEN: February 4 5, 2010

WHERE: New York Marriott Marquis Hotel
New York, NY


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. doeBilling Fully Compliant with International Billing Requirements
2. Service Corporation International Declares Quarterly Cash Dividend
3. Conference of International Experts Calls for a Focus on Well-Being and The Person in Health
4. Performance Connections International Announces New Research Focusing on the Impact of Employee Engagement in the New Economy
5. Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
6. Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share
7. Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research
8. Tyco International to Present at the Citi Industrial Manufacturing & Transportation Conference
9. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
10. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
11. Allied Worlds Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: